Latest News about COVID/19 Coronavirus
Recent news which mentions COVID/19 Coronavirus
FDA Rejects Invivyd's Request To Expand Emergency Authorization For Preventive COVID-19 Antibody For Immunocompromised Patients
February 24, 2025
From Benzinga
DeSantis Administration Cautions Against Pfizer, Moderna mRNA Covid Vaccines for Vulnerable Individuals, Cites Concerns Related To Rare Heart Conditions
September 16, 2024
From Benzinga
Americans To Access COVID-19 Test Kits For Free As US Government Restarts Free At-Home Program
August 26, 2024
From Benzinga
From Benzinga
Long Covid Remains Diagnostic Mystery, Diagnosis Remains Elusive; National Institutes of Health-Funded Study Shows
August 13, 2024
From Benzinga
Humanigen Downfall: FDA Rejection For COVID-19 Drug Triggers Financial Crisis, Bankruptcy
January 05, 2024
From Benzinga
COVAX Global Initiative For COVID-19 Vaccines Comes To An End Amid Shift To Regular Programs
December 20, 2023
From Benzinga
Timing Favors Novavax's Delayed Approval, Arrival Ahead of Peak COVID Vaccine Demand
October 09, 2023
From Benzinga
Privatized Vaccine Distribution Sparks Confusion, Payment Challenges
October 09, 2023
From Benzinga
Small Biotech Promosome Drops Lawsuit Against Pfizer, BioNTech in COVID-19 Vaccine Patent Dispute
October 05, 2023
From Benzinga
No Merck's COVID-19 Pill - US Government Ceases Free Distribution
October 05, 2023
From Benzinga
Uncertainty Looms Over Pfizer's Oral COVID-19 Antiviral Pill - Doubts Over Commercial Approval
September 27, 2023
Tickers
PFE
From Benzinga
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
September 21, 2023
From Benzinga
Updated Covid Vaccine US Rollout Hit by Insurance Coverage Delays - What It Means?
September 20, 2023
From Benzinga
Say Goodbye to Free COVID-19 Shots: CDC Approves Priced Boosters for Omicron Subvariants
September 13, 2023
From Benzinga
Is Moderna's New Vaccine the Answer to the Highly Mutated BA.2.86 COVID-19 Variant?
September 06, 2023
Tickers
MRNA
From Benzinga
Europe Approves Pfizer/BioNTech's Adapted COVID-19 Vaccine For Upcoming Autumn Vaccination Campaigns
September 01, 2023
From Benzinga
Money Stolen On Account COVID-19 Relief Fund Fraud is Shocking! US Justice Department Cracks Whip
August 24, 2023
From Benzinga
Moderna, Pfizer's Updated COVID Shot Shows Effectiveness Against 'Eris' Variant In Early Human, Preclinical Studies
August 18, 2023
From Benzinga
Virios Therapeutics Long COVID Combo Therapy Shows Improvements: Long-COVID Impacts 65M People
July 17, 2023
Tickers
VIRI
From Benzinga
Invivyd's COVID-19 Antibody Shows Favorable Safety, Tolerability Profile For Immunocompromised People
July 17, 2023
Tickers
IVVD
From Benzinga
Pfizer's COVID-19 Pill Paxlovid Underutilized in Nursing Homes Despite Proven Efficacy
July 14, 2023
Tickers
PFE
From Benzinga
Moderna Seeks European Nod For Updated COVID-19 Vaccine Shot To Tackle New Dominant Strain
July 03, 2023
Tickers
MRNA
From Benzinga
From Benzinga
Post-COVID-19: How the COVAX Initiative Could Redirect its $2.6B Surplus to Fight Future Pandemics
June 26, 2023
From Benzinga
Pfizer, Moderna, and Novavax Gear Up for XBB.1.5 Strain Targeted Vaccines as FDA AdCom Unanimously Support
June 16, 2023
From Benzinga
Cue Health Becomes First Company to Receive FDA De Novo Authorization COVID-19 Home Use Test
June 07, 2023
Tickers
HLTH
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.